ArticleFrontiers in oncology2017

Neoadjuvant Treatment of Stage IIB/III Triple Negative Breast Cancer with Cyclophosphamide, Doxorubicin, and Cisplatin (CAP Regimen): A Single Arm, Single Center Phase II Study (GBECAM 2008/02).

Arlindo R Ferreira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.